Skip to content

Clinical trials

Phase 1/2 Fallopian Tube Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20161
20171
20181
20191
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals2
Artios Pharma Ltd1
AstraZeneca1
Clovis Oncology, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
ImmunoGen, Inc.1
Medicenna Therapeutics, Inc.1
Mundipharma Research Limited1
Numab Therapeutics AG1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms11
Ovarian Neoplasms10
Endometrial Neoplasms6
Carcinoma, Ovarian Epithelial3
Colorectal Neoplasms3
Neoplasm Metastasis3
Recurrence3
Triple Negative Breast Neoplasms3
Breast Neoplasms2
Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.